Xpert MTB/RIF and Xpert Ultra for diagnosing pulmonary tuberculosis and rifampicin resistance in adults
Most Cochrane Reviews look at the effects of interventions on health, but a growing number provide evidence on how to diagnose a disease. In June 2019, one of these, on a test used to detect tuberculosis, was updated. The lead author, David Horne from the University of Washington in Seattle in the USA, sets the scene and tells us what the review found. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - October 10, 2019 Category: General Medicine Authors: Cochrane Source Type: podcasts

"Heartspeakers" -- The Discovery Files
Researchers at the University of Washington have developed a new tool to monitor people for cardiac arrest while they're asleep without touching them. The tool has the ability to scan sound recordings for signs of agonal breathing using a machine learning algorithm, which potentially could be installed in smartphones or smart speakers like Amazon Alexa. Agonal breathing, a sign of cardiac arrest, is when people suddenly become unresponsive and either stop breathing or gasp for air. (Source: The Discovery Files)
Source: The Discovery Files - June 27, 2019 Category: Science Authors: National Science Foundation Source Type: podcasts

What We Specialize In: Multidisciplinary Approach, One Stop Opinion, Consulting With Providers, Prescreening To Know If Patients Eligible
Hannah Linden MD Of The University of Washington School of Medicine Discusses What We Specialize In: Multidisciplinary Approach, One Stop Opinion, Consulting With Providers, Prescreening To Know If P... Author: Annual-Meeting Added: 06/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Palbociclib & Alpelisib: Improved Survival Benefit In Younger Breast Cancer Patients Given Palbociclib
Hannah Linden MD Of The University of Washington School of Medicine Discusses Palbociclib & Alpelisib: Improved Survival Benefit In Younger Breast Cancer Patients Given Palbociclib. Author: Annual-Meeting Added: 06/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Hired Expert In Molecular Imaging: Huge Opportunity To Bring More Experimental Tracers That Look At PARP & Progesterone Receptor Imaging
Hannah Linden MD Of The University of Washington School of Medicine Discusses Hired Expert In Molecular Imaging: Huge Opportunity To Bring More Experimental Tracers That Look At PARP & Progesterone Re... Author: Annual-Meeting Added: 06/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Estrogen Receptor Imaging: Specialty Diagnostic Test That Can Only Be Done At A Center That Can Synthesize The Tracer
Hannah Linden MD Of The University of Washington School of Medicine Discusses Estrogen Receptor Imaging: Specialty Diagnostic Test That Can Only Be Done At A Center That Can Synthesize The Tracer. Author: Annual-Meeting Added: 06/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Questions About Larotrectinib: Who Should Be Tested, How Long Should They Be Treated, What Agent To Use
Douglas S. Hawkins MD Of The University of Washington School of Medicine Discusses Questions About Larotrectinib: Who Should Be Tested, How Long Should They Be Treated, What Agent To UseBACKRO... Author: Annual-Meeting Added: 06/03/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Larotrectinib Efficacy & amp; Safety In Pediatric TRK Fusion Cancer Patients: 94% Of The Children Treated With Larotrectinib Achieved A Response
Douglas S. Hawkins MD Of The University of Washington School of Medicine Discusses Larotrectinib Efficacy & Safety In Pediatric TRK Fusion Cancer Patients: 94% Of The Children Treated With Larotre... Author: Annual-Meeting Added: 06/03/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2019 Category: Cancer & Oncology Source Type: podcasts

How To Identify Patients With An NTRK Gene Fusion: Will Require A Very Broad Genomic Sequencing
Douglas S. Hawkins MD Of The University of Washington School of Medicine Discusses How To Identify Patients With An NTRK Gene Fusion: Will Require A Very Broad Genomic Sequencing.BACKROUND: ... Author: Annual-Meeting Added: 06/03/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2019 Category: Cancer & Oncology Source Type: podcasts

PEACE III Trial Decreased Fracture Rate by Mandating Bone-protecting Agents in the EORTC 1333
Dr. Celestia Higano, MD from the University of Washington discusses the PEACE III Trial Decreased Fracture Rate by Mandating Bone-protecting Agents in the EORTC 1333Background: Skeletal fractures... Author: Annual-Meeting Added: 06/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Alliance A031201 - A phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic castration resistant prostate cancer (mCRPC)
Dr. Celestia Higano, MD of the University of Washington discusses the Alliance A031201 a phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic... Author: Annual-Meeting Added: 06/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Titan Trial Overview - Dr. Celestia Higano, MD
Dr. Celestia Higano, MD of the University of Washington discusses the Titan Trial Apalutamide vs Placebo During Androgen-Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer. At... Author: Annual-Meeting Added: 06/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Getug 16 Trial 10 Year Update
Dr. Celestia Higano, MD of the University of Washington discusses the 10 year follow up of the Getug 16 Trial from ASCO 2019 Author: Annual-Meeting Added: 06/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2019 Category: Cancer & Oncology Source Type: podcasts

SLCVL - Santana-Davila 5 Molecular marker testing for advanced NSCLC
GRACE - Global Resource for Advancing Cancer EducationPublished on Oct 25, 2016Dr. Rafael Santana-Davila, Assistant Professor of Medicine at the University of Washington, Seattle Cancer Care All... Author: cancergrace Added: 05/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - May 29, 2019 Category: Cancer & Oncology Source Type: podcasts

SLCVL - Santana-Davila 1 Basics of Lung Cancer Staging
GRACE - Global Resource for Advancing Cancer EducationPublished on Oct 25, 2016Dr. Rafael Santana-Davila, Assistant Professor of Medicine at the University of Washington, Seattle Cancer Care All... Author: cancergrace Added: 05/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - May 29, 2019 Category: Cancer & Oncology Source Type: podcasts

Nonstick chemicals that stick around and detecting ear infections with smartphones
The groundwater of Rockford, Michigan, is contaminated by per- and polyfluoroalkyl substances, chemicals found in everything from nonstick pans to dental floss to —in the case of Rockford—waterproofing agents from a shoe factory that shut down in 2009. Science journalist Sara Talpos talks with host Meagan Cantwell about how locals found the potentially health-harming chemicals in their water, and how contamination from nonstick chemicals isn’t limited t o Michigan. Also this week, host Sarah Crespi talks with Shyamnath Gollakota of the University of Washington in Seattle about his work diagnosing ear inf...
Source: Science Magazine Podcast - May 16, 2019 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts

Nonstick chemicals that stick around and detecting ear infections with smartphones
The groundwater of Rockford, Michigan, is contaminated by per- and polyfluoroalkyl substances, chemicals found in everything from nonstick pans to dental floss to —in the case of Rockford—waterproofing agents from a shoe factory that shut down in 2009. Science journalist Sara Talpos talks with host Meagan Cantwell about how locals found the potentially health-harming chemicals in their water, and how contamination from nonstick chemicals isn’t limited t o Michigan. Also this week, host Sarah Crespi talks with Shyamnath Gollakota of the University of Washington in Seattle about his work diagnosing ear inf...
Source: Science Magazine Podcast - May 16, 2019 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts

Results From KEYNOTE 365 In mCRPC
Evan Yu, MD, Professor, Department of Medicine, Division of Oncology, University of Washington, Fred Hutchinson Cancer Research Institute, Discusses Results From KEYNOTE 365 In mCRPC. At The 2019 Geni... Author: obr Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts

When Sipuleucel-T Should Be Used In Treatment Of mCRPC
Evan Yu, MD, Professor, Department of Medicine, Division of Oncology, University of Washington, Fred Hutchinson Cancer Research Institute, Discusses When Sipuleucel-T Should Be Used In Treatment Of mC... Author: obr Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts

Combining Checkpoint Inhibitors In Metastatic Castration-Resistant Prostate Cancer
Evan Yu, MD, Professor, Department of Medicine, Division of Oncology, University of Washington, Fred Hutchinson Cancer Research Institute, Discusses Combining Checkpoint Inhibitors In Metastatic Castr... Author: obr Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts

Combination Pembrolizumab And Olaparib In mCRPC
Evan Yu, MD, Professor, Department of Medicine, Division of Oncology, University of Washington, Fred Hutchinson Cancer Research Institute, Discusses Combination Pembrolizumab And Olaparib In mCRPC. At... Author: obr Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts

Uses Of Cord Blood Transplants
Filippo Milano, M.D., PhD Assistant Member Clinical Research Division, Associate Director Cord Blood Transplantation Cord Blood Program, Assistant Professor University of Washington Discusses Uses Of ... Author: ASHReport Added: 01/10/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 10, 2019 Category: Cancer & Oncology Source Type: podcasts

Cord Blood Transplants In Clinical Practice
Filippo Milano, M.D., PhD Assistant Member Clinical Research Division, Associate Director Cord Blood Transplantation Cord Blood Program, Assistant Professor University of Washington Discusses Cord Blo... Author: ASHReport Added: 01/10/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 10, 2019 Category: Cancer & Oncology Source Type: podcasts

Cord Blood Matched & Mismatched Unrelated Donors
Filippo Milano, M.D., PhD Assistant Member Clinical Research Division, Associate Director Cord Blood Transplantation Cord Blood Program, Assistant Professor University of Washington Discusses Cord Blo... Author: ASHReport Added: 01/10/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 10, 2019 Category: Cancer & Oncology Source Type: podcasts

Understanding & Using Combo Approaches With CAR T cell Therapy
Victor Chow M.D. an oncologist at the University Of Washington in Seattle, Washington discusses Understanding & Using Combo Approaches With CAR T cell Therapy At The 60th ASH Annual Meeting on Dec 1, ... Author: ASHReport Added: 01/10/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 10, 2019 Category: Cancer & Oncology Source Type: podcasts

Progressive Disease After Receiving CAR T Cell Therapy
Victor Chow M.D. an Oncologist at the University Of Washington in Seattle, Washington discusses Progressive Disease After Receiving CAR T Cell Therapy At The 60th ASH Annual Meeting on Dec 1, 2018. Author: ASHReport Added: 01/10/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 10, 2019 Category: Cancer & Oncology Source Type: podcasts

Progression Of Disease & Treatment
Victor Chow M.D. an Oncologist at the University Of Washington in Seattle, Washington discusses Progression Of Disease & Treatment At The 60th ASH Annual Meeting on Dec 1, 2018. Author: ASHReport Added: 01/10/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 10, 2019 Category: Cancer & Oncology Source Type: podcasts

Designing Prospective Trials
Victor Chow M.D. an Oncologist at the University Of Washington in Seattle, Washington discusses Designing Prospective Trials At The 60th ASH Annual Meeting on Dec 1, 2018. Author: ASHReport Added: 01/10/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 10, 2019 Category: Cancer & Oncology Source Type: podcasts

Clinical Trials For The Future
Victor Chow M.D. an oncologist at the University Of Washington in Seattle, Washington discusses Clinical Trials For The Future At The 60th ASH Annual Meeting on Dec 1, 2018. Author: ASHReport Added: 01/10/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 10, 2019 Category: Cancer & Oncology Source Type: podcasts

Cord Blood Transplants
Filippo Milano, M.D., PhD Assistant Member Clinical Research Division, Associate Director Cord Blood Transplantation Cord Blood Program, Assistant Professor University of Washington Discusses Cord Blo... Author: ASHReport Added: 12/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - December 19, 2018 Category: Cancer & Oncology Source Type: podcasts

Patient education is important for drug tolerance and adherence
In this video, recorded at the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Meeting, in Denver, CO, Jeanne McCarthy-Kaiser, PharmD, BCOP, of the University of Washington, Seattle, WA, s... Author: VJHemOnc Added: 08/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2018 Category: Cancer & Oncology Source Type: podcasts

The role of the pharmacist in transplant
Speaking from the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, Jeanne McCarthy-Kaiser, PharmD, BCOP, of the University of Washington Medical Center, Seat... Author: VJHemOnc Added: 08/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2018 Category: Cancer & Oncology Source Type: podcasts

Benefits of performing outpatient transplant
Speaking from the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, Jeanne McCarthy-Kaiser, PharmD, BCOP, of the University of Washington Medical Center, Seat... Author: VJHemOnc Added: 08/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2018 Category: Cancer & Oncology Source Type: podcasts

Chemotherapy vs. immunotherapy for the treatment of Merkel cell carcinoma
In this interview, Paul Nghiem, MD, PhD, from the University of Washington, Seattle, WA, discusses the results of the Phase II trial investigating pembrolizumab as a first-line treatment for advanced ... Author: VJOncology Added: 08/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2018 Category: Cancer & Oncology Source Type: podcasts

ALL: recent immunotherapeutic developments
In this video, Ryan Cassaday, MD, of the University of Washington, Seattle, WA, gives an overview of recent developments in the field of acute lymphoblastic leukemia (ALL). He touches upon inotuzumab ... Author: VJHemOnc Added: 07/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 30, 2018 Category: Cancer & Oncology Source Type: podcasts

Improving the SOC for ALL with inotuzumab
Speaking from the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Ryan Cassaday, MD, of the University of Washington, Seattle, WA, discusses the INO-VATE trial (NCT015647... Author: VJHemOnc Added: 07/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 30, 2018 Category: Cancer & Oncology Source Type: podcasts

Merkel Cell Carcinoma Needs to be Managed in Multidisciplinary Way | Oncology, Surgery, Radiation Therapy, Dermatology...
Paul Nghiem, MD, PhD, University of Washington, shares MCC Needs to be Managed in Multidisciplinary Way | Oncology, Surgery, Radiation Therapy, Dermatology, etc at ASCO 2018 Author: Annual-Meeting Added: 06/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 12, 2018 Category: Cancer & Oncology Source Type: podcasts

Patients Who Dont Respond to Checkpoint Therapy | Collaborating to Pick Apart Mechanisms of Resistance
Paul Nghiem, MD, PhD, University of Washington, shares Patients Who Dont Respond to Checkpoint Therapy | Collaborating to Pick Apart Mechanisms of Resistance at ASCO 2018 Author: Annual-Meeting Added: 06/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 12, 2018 Category: Cancer & Oncology Source Type: podcasts

Academic & Community Oncologists Must Collaborate | Accrue Trials to Develop New Therapies
Petros Grivas, MD, PhD, University of Washington talks about Academic & Community Oncologists Must Collaborate | Accrue Trials to Develop New Therapies at ASCO 2018 Author: Annual-Meeting Added: 06/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 12, 2018 Category: Cancer & Oncology Source Type: podcasts

Publish New Abstract Data Next Year | Complete Accrual of Estrogen Receptor Imaging
Hannah Linden, MD, University of Washington shares Publish New Abstract Data Next Year | Complete Accrual of Estrogen Receptor Imaging at ASCO 2018 Author: Annual-Meeting Added: 06/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 12, 2018 Category: Cancer & Oncology Source Type: podcasts

Dynamic Era of Changes for Urothelial Cancer | Data with FGFR Inhibitors, Antibody-Drug Conjugates
Petros Grivas, MD, PhD, University of Washington talks about Dynamic Era of Changes for Urothelial Cancer | Data with FGFR Inhibitors, Antibody-Drug Conjugates at ASCO 2018 Author: Annual-Meeting Added: 06/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 11, 2018 Category: Cancer & Oncology Source Type: podcasts

The Point of Estrogen Receptor Imaging? | If Receptor Functions & Need Endocrine Therapy
Hannah Linden, MD, University of Washington shares The Point of Estrogen Receptor Imaging? | If Receptor Functions & Need Endocrine Therapy at ASCO 2018 Author: Annual-Meeting Added: 06/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Whether Genomic Alterations Have Significance & #124; And/Or Predict Response to Individual Therapies
Petros Grivas, MD, PhD, University of Washington talks about Whether Genomic Alterations Have Significance | And-Or Predict Response to Individual Therapies at ASCO 2018 Author: Annual-Meeting Added: 06/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 11, 2018 Category: Cancer & Oncology Source Type: podcasts

ER Imaging Not Ready for Commercial Use | Working Hard With Tracer Manufacturers
Hannah Linden, MD, University of Washington shares ER Imaging Not Ready for Commercial Use | Working Hard With Tracer Manufacturers at ASCO 2018 Author: Annual-Meeting Added: 06/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Circulating Tumor DNA as a Putative Biomarker | For Patients with Advanced Urotelial Carcinoma
Petros Grivas, MD, PhD, University of Washington talks about Circulating Tumor DNA as a Putative Biomarker | For Patients with Advanced Urotelial Carcinoma at ASCO 2018 Author: Annual-Meeting Added: 06/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Estrogen Receptor Imaging | Lobular Tumors Detectable by FES PET
Hannah Linden, MD, University of Washington shares Estrogen Receptor Imaging | Lobular Tumors Detectable by FES PET Author: Annual-Meeting Added: 06/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Collaborative Community Working to Understand MCC | Do Not Need Mutational Burden to Have Response
Paul Nghiem, MD, PhD, University of Washington, shares Collaborative Community Working to Understand MCC | Do Not Need Mutational Burden to Have Response at ASCO 2018 Author: Annual-Meeting Added: 06/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Cannot Predict Who Responds to Immunotherapies | Response is 60% or More If therapy is Given First Line
Paul Nghiem, MD, PhD, University of Washington, shares Cannot Predict Who Responds to Immunotherapies | Response is 60% or More If therapy is Given First Line at ASCO 2018 Author: Annual-Meeting Added: 06/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy better than Chemo-Therapy | More Durable, Works Better in the Frontline
Paul Nghiem, MD, PhD, University of Washington, shares Immunotherapy better than Chemo-Therapy More Durable, Works Better in the Frontline at ASCO 2018 Author: Annual-Meeting Added: 06/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy & Chemo-Therapy with MCC | Response is 60% or More If therapy is Given First Line
Paul Nghiem, MD, PhD, University of Washington, shares Immunotherapy & Chemo-Therapy with MCC Response is 60% or More If therapy is Given First Line at ASCO 2018 Author: Annual-Meeting Added: 06/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 9, 2018 Category: Cancer & Oncology Source Type: podcasts